Most venture capital funds claim to engage in “active management,” while in fact doing little more than assuming passive board roles. AIM-HI is actively involved with each of its portfolio companies.
AIM-HI hosts a series of Shark Tank style pitch competitions. We provide two forums—one for the National Foundation for Cancer Research’s Salisbury Award program and another for aspiring female entrepreneur-scientists.
We estimate that the U.S. spends about $20 billion a year on cancer research, but only 0.5 percent of that goes toward translating research out of the lab, where it can change and save lives. AIM-HI is helping to address that discrepancy.
Portfolio Companies
Our Mission
The AIM-HI Accelerator Fund is an independent 501(C)(3) non-profit organization, established with an initial grant from the National Foundation for Cancer Research with the vision to accelerate the translation of cancer drug discoveries by investing in seed-stage companies. It is a new paradigm through venture philanthropy to fund start-up oncology companies that commercialize innovative laboratory breakthroughs which can potentially save cancer patients’ lives.
AIM-HI Women Bioentrepreneurs Venture Competition - win up to $300,000 in seed funding!
